The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Bombesin functionalized gold nanoparticles show in vitro and in vivo cancer receptor specificity
Open accessAbstract
Development of cancer receptor-specific gold nanoparticles will allow efficient targeting/optimum retention of engineered gold nanoparticles within tumors and thus provide synergistic advantages in oncology as it relates to molecular imaging and therapy. Bombesin (BBN) peptides have demonstrated high affinity toward gastrin-releasing peptide (GRP) receptors in vivo that are overexpressed in prostate, breast, and small-cell lung carcinoma. We have synthesized a library of GRP receptor-avid nanoplatforms by conjugating gold nanoparticles (AuNPs) with BBN peptides. Cellular interactions and binding affinities (IC 50 ) of AuNP–BBN conjugates toward GRP receptors on human prostate cancer cells have been investigated in detail. In vivo studies using AuNP–BBN and its radiolabeled surrogate 198 AuNP–BBN, exhibiting high binding affinity (IC 50 in microgram ranges), provide unequivocal evidence that AuNP–BBN constructs are GRP-receptor-specific showing accumulation with high selectivity in GRP-receptor-rich pancreatic acne in normal mice and also in tumors in prostate-tumor-bearing, severe combined immunodeficient mice. The i.p. mode of delivery has been found to be efficient as AuNP–BBN conjugates showed reduced RES organ uptake with concomitant increase in uptake at tumor targets. The selective uptake of this new generation of GRP-receptor-specific AuNP–BBN peptide analogs has demonstrated realistic clinical potential in molecular imaging via x-ray computed tomography techniques as the contrast numbers in prostate tumor sites are severalfold higher as compared to the pretreatment group (Hounsfield unit = 150).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Jain, P. K., Huang, X., El-Sayed, I. H., & El-Sayed, M. A. (2008) · Accounts of Chemical Research · doi:10.1021/ar7002804 · Cited by 4,215
Mortality Results from a Randomized Prostate-Cancer Screening Trial
Andriole, G. L., Crawford, E. D., Grubb, R. L., Buys, S. S., Chia, D., Church, T. R., Fouad, M. N., Gelmann, E. P., Kvale, P. A., Reding, D. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810696 · Cited by 2,906
Gold nanoparticles: a new X-ray contrast agent
Hainfeld, J. F., Slatkin, D. N., Focella, T. M., & Smilowitz, H. M. (2006) · The British Journal of Radiology · doi:10.1259/bjr/13169882 · Cited by 1,351
Microscopy of starch: evidence of a new level of granule organization
Gallant, D. J., Bouchet, B., & Baldwin, P. M. (1997) · Carbohydrate Polymers · doi:10.1016/s0144-8617(97)00008-8 · Cited by 1,049
Dhar, S., Gu, F. X., Langer, R., Farokhzad, O. C., & Lippard, S. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809154105 · Cited by 994
Targeted Gold Nanoparticles Enable Molecular CT Imaging of Cancer
Popovtzer, R., Agrawal, A., Kotov, N. A., Popovtzer, A., Balter, J., Carey, T. E., & Kopelman, R. (2008) · Nano Letters · doi:10.1021/nl8029114 · Cited by 801
Kupffer cells are central in the removal of nanoparticles from the organism
Sadauskas, E., Wallin, H., Stoltenberg, M., Vogel, U., Doering, P., Larsen, A., & Danscher, G. (2007) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-4-10 · Cited by 607
Zhang, G., Yang, Z., Lu, W., Zhang, R., Huang, Q., Tian, M., Li, L., Liang, D., & Li, C. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.12.038 · Cited by 563
Thaxton, C. S., Elghanian, R., Thomas, A. D., Stoeva, S. I., Lee, J.-S., Smith, N. D., Schaeffer, A. J., Klocker, H., Horninger, W., Bartsch, G., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904719106 · Cited by 388
Kattumuri, V., Katti, K., Bhaskaran, S., Boote, E. J., Casteel, S. W., Fent, G. M., Robertson, D. J., Chandrasekhar, M., Kannan, R., & Katti, K. V. (2007) · Small · doi:10.1002/smll.200600427 · Cited by 380
Self-citationTargeted Delivery of Gemcitabine to Pancreatic Adenocarcinoma Using Cetuximab as a Targeting Agent
Patra, C. R., Bhattacharya, R., Wang, E., Katarya, A., Lau, J. S., Dutta, S., Muders, M., Wang, S., Buhrow, S. A., Safgren, S. L., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6102 · Cited by 371
Heath, J. R., & Davis, M. E. (2008) · Annual Review of Medicine · doi:10.1146/annurev.med.59.061506.185523 · Cited by 354
Howard, K. A., Paludan, S. R., Behlke, M. A., Besenbacher, F., Deleuran, B., & Kjems, J. (2009) · Molecular Therapy · doi:10.1038/mt.2008.220 · Cited by 299
Chanda, N., Kan, P., Watkinson, L. D., Shukla, R., Zambre, A., Carmack, T. L., Engelbrecht, H., Lever, J. R., Katti, K., Fent, G. M., et al. (2010) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2009.11.001 · Cited by 238
Self-citationHuang, H.-C., Barua, S., Kay, D. B., & Rege, K. (2009) · ACS Nano · doi:10.1021/nn900947a · Cited by 180
Reile, H., Armatis, P. E., & Schally, A. V. (1994) · The Prostate · doi:10.1002/pros.2990250105 · Cited by 166
Imaging techniques for prostate cancer: implications for focal therapy
Türkbey, B., Pinto, P. A., & Choyke, P. L. (2009) · Nature Reviews Urology · doi:10.1038/nrurol.2009.27 · Cited by 150
Chanda, N., Shukla, R., Katti, K. V., & Kannan, R. (2009) · Nano Letters · doi:10.1021/nl8037147 · Cited by 127
Self-citationProstate cancer: diagnosis and staging
Borley, N., & Feneley, M. R. (2008) · Asian Journal of Andrology · doi:10.1038/aja.2008.19 · Cited by 110
Smith, C. J., Gali, H., Sieckman, G. L., Hayes, D. L., Owen, N. K., Mazuru, D. G., Volkert, W. A., & Hoffman, T. J. (2003) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(02)00391-8 · Cited by 107
Self-citationNanoparticle-Delivered Suicide Gene Therapy Effectively Reduces Ovarian Tumor Burden in Mice
Huang, Y.-H., Zugates, G. T., Peng, W., Holtz, D. O., Dunton, C. J., Green, J. J., Hossain, N., Chernick, M. R., Padera, R. F., Langer, R., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0061 · Cited by 92
Lymphatic Targeting of Polymeric Nanoparticles After Intraperitoneal Administration in Rats
Maincent, P., Thouvénot, P., Amicabile, C., Hoffman, M., Kreuter, J., Couvreur, P., & Devissaguet, J. P. (1992) · Pharmaceutical Research · doi:10.1023/a:1015895804597 · Cited by 76
Cited by
Nanotechnology in Drug Delivery and Tissue Engineering: From Discovery to Applications
Shi, J., Votruba, A. R., Farokhzad, O. C., & Langer, R. (2010) · Nano Letters · doi:10.1021/nl102184c · Cited by 1,612
X-ray-Computed Tomography Contrast Agents
Lusic, H., & Grinstaff, M. W. (2013) · Chemical Reviews · doi:10.1021/cr200358s · Cited by 1,108
Nanomedicine(s) under the Microscope
Duncan, R., & Gaspar, R. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200394t · Cited by 981
Recent Progress in Cancer Thermal Therapy Using Gold Nanoparticles
Abadeer, N. S., & Murphy, C. J. (2016) · The Journal of Physical Chemistry C · doi:10.1021/acs.jpcc.5b11232 · Cited by 919
Functionalized Gold Nanoparticles and Their Biomedical Applications
Tiwari, P. M., Vig, K., Dennis, V. A., & Singh, S. R. (2011) · Nanomaterials · doi:10.3390/nano1010031 · Cited by 840
Metadata
- Authors
- Chanda, N., Kattumuri, V., Shukla, R., Zambre, A., Katti, K., Upendran, A., Kulkarni, R. R., Kan, P., Fent, G. M., Casteel, S. W., Smith, C. J., Boote, E., Robertson, J. D., Cutler, C., Lever, J. R., Katti, K. V., & Kannan, R.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2010-04-21
- Volume
- 107
- Issue
- 19
- Pages
- 8760-8765
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2029804518
- Cited by
- 321
- References
- 23
- FWCI
- 20.49
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.